Release Summary

CytoDyn Announces Phase IIB Clinical Trial Agreement with Dr Jeffrey Jacobson, Drexel University College of Medicine for PRO 140, an experimental humanized monoclonal antibody for the treatment of HIV

CytoDyn Inc.